United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Why Cognizant is betting on context engineers to lead the next wave of enterprise AI adoption Cognizant’s 1,000 context engineer initiative aims to close the AI alignment gap with Workfabric’s ContextFabric. Explore what it means for enterprise AI at scale. byPallavi MadhirajuAugust 31, 2025